Loading...
XNASASTC
Market cap11mUSD
Dec 27, Last price  
6.91USD
1D
-0.43%
1Q
-15.79%
Jan 2017
-7.93%
Name

Astrotech Corp

Chart & Performance

D1W1MN
XNAS:ASTC chart
P/E
—
P/S
7.06
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
58.32%
Rev. gr., 5y
67.29%
Revenues
2m
+121.87%
59,401,00050,746,00052,762,00025,544,00031,985,00027,979,00020,149,00026,138,00023,995,00016,423,000513,0002,671,0002,328,00086,000127,000488,000334,000869,000750,0001,664,000
Net income
-12m
L+20.99%
5,249,000-12,397,000-16,292,000-36,028,0004,725,000260,000-4,983,000-2,713,000-185,000-4,960,00010,778,000-13,095,000-11,582,000-13,251,000-7,534,000-8,508,000-7,606,000-7,564,000-9,642,000-11,666,000
CFO
-10m
L+27.54%
-7,153,0003,984,00012,310,000-8,598,0004,972,0004,437,0009,234,000-4,109,000-2,902,000-552,000-10,858,000-13,324,000-8,821,000-10,784,000-8,475,000-6,931,000-7,410,000-6,792,000-7,625,000-9,725,000
Earnings
Feb 10, 2025

Profile

Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.
URL
https://www.astrotechcorp.com/
IPO date
Dec 21, 1995
Employees
14
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
1,664
121.87%
750
-13.69%
869
160.18%
Cost of revenue
14,944
11,810
9,464
Unusual Expense (Income)
NOPBT
(13,280)
(11,060)
(8,595)
NOPBT Margin
Operating Taxes
2
(489)
(766)
Tax Rate
NOPAT
(13,282)
(10,571)
(7,829)
Net income
(11,666)
20.99%
(9,642)
27.47%
(7,564)
-0.55%
Dividends
Dividend yield
Proceeds from repurchase of equity
(119)
BB yield
0.52%
Debt
Debt current
454
632
734
Long-term debt
373
898
840
Deferred revenue
Other long-term liabilities
232
Net debt
(31,089)
(40,597)
(51,052)
Cash flow
Cash from operating activities
(9,725)
(7,625)
(6,792)
CAPEX
(579)
(1,844)
(596)
Cash from investing activities
6,140
(3,844)
(596)
Cash from financing activities
(181)
(776)
(2,095)
FCF
(13,074)
(12,420)
(8,760)
Balance
Cash
31,916
42,127
52,626
Long term investments
Excess cash
31,833
42,090
52,583
Stockholders' equity
(47,554)
(36,164)
(26,269)
Invested Capital
82,777
81,806
80,540
ROIC
ROCE
EV
Common stock shares outstanding
1,638
1,620
1,590
Price
8.90
-37.15%
14.16
3,193.02%
0.43
-67.67%
Market cap
14,578
-36.45%
22,939
3,255.02%
684
-29.85%
EV
(16,511)
(17,658)
(50,368)
EBITDA
(12,406)
(10,571)
(8,359)
EV/EBITDA
1.33
1.67
6.03
Interest
265
Interest/NOPBT